2021 Outlook: Five Themes That Will Define Co-Pay Assistance

As the pharmaceutical industry turns the calendar to 2021, co-pay assistance faces a handful of significant considerations that will define how successful manufacturer programs are in the year ahead. From legislative and regulatory issues to the shift toward integrated offerings and interoperable technologies, co-pay has become a complex facet of any brand’s patient access strategy. Understanding these themes and developing a detailed strategy around them will be key to positioning a program for success both in the immediate year ahead and into the future.

About TrialCard
TrialCard Incorporated provides patient affordability, medication access and adherence, patient support, and clinical trial services on behalf of pharmaceutical manufacturers. Founded in 2000, TrialCard has connected nearly 33 million patients with over $15 billion in branded drug savings to date. Our attention to detail, commitment to our clients, and locations in areas that are rich in healthcare talent allow us to provide levels of service that are unsurpassed in our industry. The company is headquartered in Morrisville, North Carolina. For more information about TrialCard, please visit www.trialcard.com.